BioLife solutions signs multi-year supply agreement with Qkine Limited to expand its product portfolio into the rapidly growing cytokines market

BOTHELL, Wash. —BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year supply agreement with Qkine Limited under which BioLife will distribute certain ctokine and growth factor products manufactured by Qkine for use in cell and gene [...]

Apertura Gene Therapy Launches Open Aperture, a Material Transfer Agreement Program to Facilitate Non-Commercial Access to TfR1 CapX for Academic Researchers

— Open Aperture provides no-cost access to TfR1 CapX, a leading central nervous system-targeting AAV capsid — NEW YORK, NY – Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced the launch of Open Aperture, a material transfer agreement program that provides qualified academic researchers with access to [...]

New England Biolabs® launches Monarch® Mag Cell-free DNA (cfDNA) Extraction Kit to enable scalable, reproducible cfDNA isolation from biofluids

The automation-compatible, bead-based method optimizes cfDNA recovery from plasma, serum, urine and cerebrospinal fluid IPSWICH, Mass. -- New England Biolabs (NEB®) announces the release of the Monarch Mag Cell-free DNA (cfDNA) Extraction Kit, which enables consistent, scalable extraction of low-abundance, circulating cell-free DNA (cfDNA) for downstream applications including biomarker discovery and diagnostics development. The magnetic, bead-based workflow is [...]

HighRes® and NVIDIA Partner to Advance AI-Driven Autonomous Laboratories

Beverly, MA — HighRes® today announced an expanding collaboration with NVIDIA focused on applying AI to make laboratory automation more reliable, adaptive, and accessible, paving the way toward fully autonomous laboratories. HighRes and NVIDIA share a vision that AI is the key to unlocking the next generation of lab automation, where systems are no longer [...]

BioLife solutions signs multi-year supply agreement with Qkine Limited to expand its product portfolio into the rapidly growing cytokines market

BOTHELL, Wash. — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year supply agreement with Qkine Limited under which BioLife will distribute certain ctokine and growth factor products manufactured by Qkine for use in cell and [...]

JULABO USA App First to Integrate LiDAR Technology Ensuring Safe Refrigerant Use in Labs

Updated app includes personalized product recommendations for enhanced safety compliance ALLENTOWN, Pa. -- JULABO USA announces an update today to its smartphone application, integrating advanced LiDAR technology. This enhancement is designed to assist laboratories in accurately assessing their space for the safe deployment of liquid temperature control units, particularly as the industry transitions to natural refrigerants. This [...]

PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner

Integration of HiFi Long-Read Whole-Genome Sequencing Expands the Collective Capabilities of iHope’s Global Rare Disease Network MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced a collaboration with iHope, a global rare disease genomics program of Genetic Alliance, to integrate PacBio’s HiFi® long-read whole-genome sequencing into iHope’s [...]

Stellaromics Appoints Industry Veterans Stacie Weninger and Steve McPhail to Board of Directors

Appointments to bolster rapid scaling and execution of Pyxa™ spatial platform BOSTON -- Stellaromics, a pioneer in high-resolution 3D spatial multi-omics, today announced the appointment of Stacie Weninger, PhD, and Steve McPhail to its Board of Directors. These strategic appointments come at a pivotal time for the company as it scales its innovative Pyxa™ technology and [...]

Bio-Techne Announces Changes to its Leadership Team

Dr. Matt McManus to transition from his role as President, Diagnostics and Spatial Biology Segment, effective March 1, 2026 Steve Crouse, Senior Vice President of Bio-Techne's Analytical Solutions Division, has been appointed President, Diagnostics and Spatial Biology Segment, effective March 1, 2026 MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Dr. Matt McManus, President [...]

Change on Endress+Hauser Supervisory Board

Steven Endress to succeed Matthias Altendorf as Supervisory Board President The Endress+Hauser Group’s generational handover continues. The Swiss measurement and automation technology specialist has already announced a sweeping refresh of the Executive Board made necessary by the planned retirement of several long-serving members. Now the time is nearing for a change at the helm of [...]

Access IBO on Knowledge Center